Low energy proton beam induces efficient cell killing in A549 lung adenocarcinoma cells

Cancer Investigation

Volumn 28, Issue 6, 2010, Pages 615-622

  Ghosh, Somnath ^a   Bhat, Nagesh N ^a   Santra, S ^a   Thomas, R G ^a   Gupta, S K ^a   Choudhury, R K ^a   Krishna, Malini ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

ATM; Bax; Bcl 2; P53; Proton beam

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CHECKPOINT KINASE 2; DNA DEPENDENT PROTEIN KINASE; HISTONE H2AX; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY; GAMMA RADIATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LOW ENERGY RADIATION; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTON RADIATION; RADIATION DOSE; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE PROTEINS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DNA DAMAGE; DNA-BINDING PROTEINS; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; LUNG NEOPLASMS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTONS; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 77953205843     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357901003630991     Document Type: Article

References (39)

1. Krengli, M.; Hug, E.B.; Adams, J.A.; Smith, A.R.; Tarbell, N.J.; Munzenrider, J.E. Proton radiation therapy for retinoblastoma: comparison of various intraocular tumor locations and beam arrangements. Int J Radiat Oncol Biol Phys 2005, 61, 583-593.
2. St Clair, W.H.; Adams, J.A.; Bues, M.; Fullerton, B.C.; La Shell, S.; Kooy, H.M.; Loeffler, J.S.; Tarbell, N.J. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys 2004, 58, 727-734.
3. Miralbell, R.; Crowell, C.; Suit, H.D. Potential improvement of three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer. Int J Radiat Oncol Biol Phys 1992, 22, 305-310.
4. Jones, B.; Dale, R.G.; Cárabe-Fernández, A. Charged particle therapy for cancer: the inheritance of the Cavendish scientists? Appl Radiat Isot 2009, 67, 371-377.
5. Chang, J.Y.; Zhang, X.; Wang, X.; Kang, Y.; Riley, B.; Bilton, S.; Mohan, R.; Komaki, R.; Cox, J.D. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 65, 1087-1096.
6. Fukumitsu, N.; Sugahara, S.; Nakayama, H.; Fukuda, K.; Mizumoto, M.; Abei, M.; Shoda, J.; Thono, E.; Tsuboi, K.; Tokuuye, K. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2009, 74, 831-836.
7. Shibuya, K.; Mathers, C.D.; Boschi-Pinto, C.; Lopez, A.D.; Murray, C.J. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2002, 2, 37.
8. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M.J. Cancer statistics, 2008. CA Cancer J Clin 2008, 58, 71-96.
9. Ferlay, J.; Autier, P.; Boniol, M.; Heanue, M.; Colombet, M.; Boyle, P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007, 18, 581-592.
10. Jassem J. The role of radiotherapy in lung cancer: where is the evidence? Radiother Oncol 2007, 83, 203-213.
11. Kim, Y.S.; Yoon, S.M.; Choi, E.K.; Yi, B.Y.; Kim, J.H.; Ahn, S.D.; Lee, S.W.; Shin, S.S.; Lee, J.S.; Suh, C.; Kim, S.W.; Kim, D.S.; Kim, W.S.; Park, H.J.; Park, C.I. Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2005, 62, 76-81.
12. Farray, D.; Mirkovic, N.; Albain, K.S. Multimodality therapy for stage III non-small-cell lung cancer. J Clin Oncol 2005, 23, 3257-3269.
13. Bush, D.A.; Slater, J.D.; Bonnet, R.; Cheek, G.A.; Dunbar, R.D.; Moyers, M.; Slater, J.M. Proton-beam radiotherapy for early-stage lung cancer. Chest 1999, 116, 1313-1319.
14. Shioyama, Y.; Tokuuye, K.; Okumura, T.; Kagei, K.; Sugahara, S.; Ohara, K.; Akine, Y.; Ishikawa, S.; Satoh, H.; Sekizawa, K. Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2003; 56: 7-13.
15. Koto, M.; Miyamoto, T.; Yamamoto, N.; Nishimura, H.; Yamada, S.; Tsujii, H. Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol 2004, 71, 147-156.
16. Maser, R.S.; Monsen, K.J.; Nelms, B.E.; Petrini, J.H. hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol Cell Biol 1997, 17, 6087-6096.
17. Fernandez-Capetillo, O.; Lee, A.; Nussenzweig, M.; Nussenzweig, A. H2AX: the histone guardian of the genome. DNA Repair 2004, 3, 959-967.
18. Bekker-Jensen, S.; Lukas, C.; Kitagawa, R.; Melander, F.; Kastan, M.B.; Bartek, J.; Lukas, J. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J Cell Biol 2006, 173, 195-206.
19. Goto, S.; Watanabe, M.; Yatagai, F. Delayed cell cycle progression in human lymphoblastoid cells after exposure to high-LET radiation correlates with extremely localized DNA damage. Radiat Res 2002, 158, 678-686.
20. Stenerlow, B.; Hoglund, E.; Carlsson, J.; Blomquist, E. Rejoining of DNA fragments produced by radiations of different linear energy transfer. Int J Radiat Biol 2000, 76, 549-557.
21. Lee, K.B.; Lee, J.S.; Park, J.W.; Huh, T.L.; Lee, Y.M. Low energy proton beam induces tumor cell apoptosis through reactive oxygen species and activation of caspases. Exp Mol Med 2008, 40, 118-129
22. Ghosh, S.; Maurya, D.K.; Krishna, M. Role of iNOS in bystander signaling between macrophages and lymphoma cells. Int J Radiat Oncol Boil Phy 2008, 72, 1567-1574
23. Rasband, W.S. and Image, J.U.S. National Institutes of Health, Bethesda, USA, http://rsb.info.nih.gov/ij/ (1997-2006).
24. Khanna, K.K.; Lavin, M.F.; Jackson, S.P.; Mulhern, T.D. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ 2001, 8(11), 1052-1065.
25. Lakin, N.D.; Jackson, S.P. Regulation of p53 in response to DNA damage. Oncogene 1999, 18, 7644-7655.
26. Rich, T.; Allen, R.L.; Wyllie, A.H. Defying death after DNA damage. Nature 2000, 407, 777-783.
27. Wang, H.; Zeng, Z.C.; Bui, T.A.; DiBiase, S.J.; Qin, W.; Xia, F.; Powell, S.N.; Iliakis, G. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2. Cancer Res 2001, 61, 270-277
28. Rogakou, E.P.; Pilch, D.R.; Orr, A.H.; Ivanova, V.S.; Bonner, W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998, 273, 5858-5868.
29. Olive, P.L.; Banath, J.P. Phosphorylation of histone H2AX as a measure of radiosensitivity. Int J Radiat Oncol Biol Phys 2004, 58, 331-335.
30. Burma, S.; Kurimasa, A.; Xie, G.; Taya, Y.; Araki, R.; Abe, M.; Crissman, H.A.; Ouyang, H.; Li, G.C.; Chen, D.J. DNA-dependent protein kinase-independent activation of p53 in response to DNA damage. J Biol Chem 1999, 274, 17139-17143.
31. Wang, S.; Guo, M.; Ouyang, H.; Li, X.; Cordon-Cardo, C.; Kurimasa, A.; Chen, D.J.; Fuks, Z.; Ling, C.C.; Li, G.C. The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest. Proc Natl Acad Sci USA 2000, 97, 1584-1588.
32. Fei, P.; Bernhard, E.J.; El-Deiry, W.S. Tissue-specific induction of p53 targets in vivo. Cancer Res 2002, 62, 7316-7327.
33. Yonish-Rouach, E.; Resnitzky, D.; Lotem, J.; Sachs, L.; Kimchi, A.; Oren, M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991, 352, 345-347.
34. Sabbatini, P.; Lin, J.; Levine, A.J.; White, E. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev 1995, 9, 2184-2192.
35. Caelles, C.; Helmberg, A.; Karin, M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994, 370, 220-223.
36. Polyak, K.; Xia, Y.; Zweier, J.L.; Kinzler, K.W.; Vogelstein, B. A model for p53-induced apoptosis. Nature 1997, 389, 300-305.
37. Mihara, M.; Erster, S.; Zaika, A.; Petrenko, O.; Chittenden, T.; Pancoska, P.; Moll, U.M. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003, 11, 577-590.
38. Fei, P.; El-Deiry, W.S. p53 and radiation responses. Oncogene 2003, 22, 5774-5783.
39. Mitra, A.K.; Bhat, N.; Sarma, A.; Krishna, M. Alteration in the expression of signaling parameters following carbon ion irradiation. Mol Cell Biochem 2005, 276(1-2), 169-173.